NCT01926054View on ClinicalTrials.gov

ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
SLE Glomerulonephritis Syndrome, WHO Class V
Interventions
DRUG

Acthar gel

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center, Nephrology Clinical Trials Unit, Columbus

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Ohio State University

OTHER

NCT01926054 - ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis | Biotech Hunter | Biotech Hunter